BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 37762070)

  • 1. CTC, ctDNA, and Exosome in Thyroid Cancers: A Review.
    Wang W; Zheng Z; Lei J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
    Muhanna N; Eu D; Chan HHL; Douglas C; Townson JL; Di Grappa MA; Mohamadi RM; Kelley SO; Bratman SV; Irish JC
    BMC Cancer; 2021 Oct; 21(1):1075. PubMed ID: 34600526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy.
    Wang X; Wang L; Lin H; Zhu Y; Huang D; Lai M; Xi X; Huang J; Zhang W; Zhong T
    Front Oncol; 2024; 14():1303335. PubMed ID: 38333685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.
    Zhu Y; Zhang H; Chen N; Hao J; Jin H; Ma X
    Medicine (Baltimore); 2020 Jan; 99(3):e18581. PubMed ID: 32011436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-based liquid biopsies in cancer: opportunities and challenges.
    Yu W; Hurley J; Roberts D; Chakrabortty SK; Enderle D; Noerholm M; Breakefield XO; Skog JK
    Ann Oncol; 2021 Apr; 32(4):466-477. PubMed ID: 33548389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 11. Liquid biopsies in thyroid cancers: a systematic review and meta-analysis.
    Zeyghami W; Hansen MU; Jakobsen KK; Groenhøj C; Feldt-Rasmussen U; von Buchwald C; Hahn CH
    Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37882489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma.
    Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A
    Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer diagnosis: from tumor to liquid biopsy and beyond.
    Vaidyanathan R; Soon RH; Zhang P; Jiang K; Lim CT
    Lab Chip; 2018 Dec; 19(1):11-34. PubMed ID: 30480287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of liquid biopsy in the management of cancer patients.
    Markou A; Tzanikou E; Lianidou E
    Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
    Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
    J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
    Wang K; Wang X; Pan Q; Zhao B
    Mol Cancer; 2023 Oct; 22(1):167. PubMed ID: 37803304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy in ovarian cancer.
    Giannopoulou L; Lianidou ES
    Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.